tiprankstipranks
Trending News
More News >
UCB SA (DE:UNC)
XETRA:UNC

UCB SA (UNC) Similar Stocks

Compare
35 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
UCB SA
€240.80
€44.74B
34.35
26.62%
8 Buy
1 Hold
1 Sell
Moderate Buy
UCB SA
€236.53
€44.74B
33.74
24.20%
8 Buy
1 Hold
1 Sell
Moderate Buy
AstraZeneca
13674.00p
£211.99B
29.45
34.22%
12 Buy
2 Hold
1 Sell
Moderate Buy
GlaxoSmithKline
1805.50p
£72.84B
13.35
40.40%
3 Buy
9 Hold
3 Sell
Hold
Hikma Pharmaceuticals
1533.00p
£3.38B
11.83
-20.08%
4 Buy
1 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
DE:UNC
UCB SA
240.80
50.63
26.62%
GB:0NZT
UCB SA
236.53
49.05
26.16%
GB:AZN
AstraZeneca
13,674.00
3,486.58
34.22%
GB:GSK
GlaxoSmithKline
1,805.50
527.71
41.30%
GB:HIK
Hikma Pharmaceuticals
1,533.00
-387.13
-20.16%
GB:INDV
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts